NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

WHO Recommendations on the Diagnosis of HIV Infection in Infants and Children. Geneva: World Health Organization; 2010.

Cover of WHO Recommendations on the Diagnosis of HIV Infection in Infants and Children

WHO Recommendations on the Diagnosis of HIV Infection in Infants and Children.

Show details

REFERENCES

1.
World Health Organization; Joint United Nations Programme on HIV/AIDS (UNAIDS) and United Nations Children Fund (UNICEF). Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report 2008. Geneva: World Health Organization; 2008. http://whqlibdoc​.who​.int/publications/2008​/9789241596886_eng.pdf.
2.
World Health Organization; Joint United Nations Programme on HIV/AIDS (UNAIDS) and United Nations Children Fund (UNICEF). Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report 2009. Geneva: World Health Organization; 2009. http://whqlibdoc​.who​.int/publications/2009​/9789241598750_eng.pdf.
3.
Joint United Nations Programme on HIV/AIDS (UNAIDS); World Health Organization. AIDS epidemic update: December 2009. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2009. http://whqlibdoc​.who​.int/unaids/2009/9789291738328_eng.pdf.
4.
Isaakidis P, et al. High survival and treatment success sustained after two and three years of first-line ART for children in Cambodia. Journal of the International AIDS Society. 2010;13(1):11. [PMC free article: PMC2851581] [PubMed: 20302672]
5.
Sutcliffe CG, et al. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infectious Diseases. 2008;8(8):477–489. [PubMed: 18652994]
6.
Janssens B, et al. Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia. Pediatrics. 2007;120(5):e1134–1140. [PubMed: 17954553]
7.
HIV Paediatric Prognostic Markers Collaborative Study. Predictive value of absolute CD4 cell count for disease progression in untreated HIV-1-infected children. AIDS. 2006;20(9):1289–1294. [PubMed: 16816558]
8.
Violari A, et al. Early antiretroviral therapy and mortality among HIV-infected infants. New England Journal of Medicine. 2008;359(21):2233–2244. [PMC free article: PMC2950021] [PubMed: 19020325]
9.
Chiappini E, et al. Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection. AIDS. 2006;20(2):207–215. [PubMed: 16511413]
10.
Prendergast A, et al. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants. AIDS. 2008;22(11):1333–1343. [PubMed: 18580613]
11.
Report of the WHO Technical Reference Group, Paediatric HIV/ART Care Guideline Group Meeting. Geneva: World Health Organization; 2008. http://www​.who.int/hiv​/pub/paediatric/WHO​_Paediatric_ART_guideline​_rev_mreport_2008.pdf)
12.
Antiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach. Geneva: World Health Organization; 2007. http://whqlibdoc​.who​.int/publications/2007​/9789241594691_eng.pdf. [PubMed: 23741772]
13.
WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva: World Health Organization; 2007. http://whqlibdoc​.who​.int/publications/2007​/9789241595629_eng.pdf.
14.
Guidance on provider-initiated HIV testing and counselling in health facilities. Geneva: World Health Organization; 2007. http://whqlibdoc​.who​.int/publications/2007​/9789241595568_eng.pdf.
15.
Guyatt GH, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. British Medical Journal. 2008;336(7650):924–926. [PMC free article: PMC2335261] [PubMed: 18436948]
16.
Kunz R, et al. Das GRADE-System : Ein internationaler Ansatz zur Vereinheitlichung der Graduierung von Evidenz und Empfehlungen in Leitlinien. [The GRADE System. An international approach to standardize the graduation of evidence and recommendations in guidelines]. Internist. 2008;49(6):673–680. [PubMed: 18461295]
17.
Gleaves CA, et al. Multicenter evaluation of the Bayer VERSANT HIV-1 RNA 3.0 assay: analytical and clinical performance. Journal of Clinical Virology. 2002;25(2):205–216. [PubMed: 12367656]
18.
Cachafeiro A, et al. Diagnosis of human immunodeficiency virus type 1 infection in infants by use of dried blood spots and an ultrasensitive p24 antigen assay. Journal of Clinical Microbiology. 2009;47(2):459–462. [PMC free article: PMC2643698] [PubMed: 19073872]
19.
UNAIDS/WHO Working Group on Global HIV/AIDS/STI Surveillance. Initiating second generation HIV surveillance systems for definitions of HIV epidemic types: practical guidelines. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2002. http://www​.who.int/hiv​/pub/surveillance/en/isbn9291732192​.pdf.
20.
Gulia J, et al. HIV seroreversion time in HIV-1-uninfected children born to HIV-1-infected mothers in Malawi. Journal of Acquired Immune Deficiency Syndromes. 2007;46(3):332–337. [PubMed: 17786126]
21.
Sohn AH, et al. Failure of human immunodeficiency virus enzyme immunoassay to rule out infection among polymerase chain reaction-negative vietnamese infants at 12 months of age. Pediatric Infectious Disease Journal. 2009;28(4):273–276. [PMC free article: PMC2712114] [PubMed: 19289981]
22.
Tumwesigye N, et al. Validation of the clinical criteria for presumptive diagnosis of severe HIV disease in infants and children under 18 months, requiring ART in situations where virological testing is not available; 17th Conference on retroviruses and opportunistic infections; San Francisco, USA. 2010; Poster. http://www​.retroconference​.org/2010/PDFs/842.pdf.
23.
WHO recommendations for routine immunization - summary tables. 2009. [1 August 2009]. http://www​.who.int/immunization​/policy/immunization_tables​/en/index.html.
24.
Parekh BS, et al. Dynamics of maternal IgG antibody decay and HIV-specific antibody synthesis in infants born to seropositive mothers. The NYC Perinatal HIV Transmission Study Group. AIDS Research and Human Retroviruses. 1993;9(9):907–912. [PubMed: 8257638]
25.
Chantry CJ, et al. Seroreversion in human immunodeficiency virus-exposed but uninfected infants. Pediatric Infectious Disease Journal. 1995;14(5):382–387. [PubMed: 7638014]
26.
Rakusan TA, et al. Limitations in the laboratory diagnosis of vertically acquired HIV infection. Journal of Acquired Immune Deficiency Syndromes. 1991;4(2):116–121. [PubMed: 1987348]
27.
McIntosh K, et al. A comparison of peripheral blood coculture versus 18- or 24-month serology in the diagnosis of human immunodeficiency virus infection in the offspring of infected mothers. Women and Infants Transmission Study. Journal of Infectious Diseases. 1998;178(2):560–563. [PubMed: 9697744]
28.
Jones DS, et al. Lack of detectable human immunodeficiency virus infection in antibody-negative children born to human immunodeficiency virus-infected mothers. Pediatric Infectious Disease Journal. 1993;12(3):222–227. [PubMed: 8451099]
29.
Moodley D, et al. Predicting perinatal human immunodeficiency virus infection by antibody patterns. Pediatric Infectious Disease Journal. 1995;14(10):850–852. [PubMed: 8584310]
30.
Parekh BS, et al. Human immunodeficiency virus 1-specific IgA capture enzyme immunoassay for early diagnosis of human immunodeficiency virus 1 infection in infants. NYC Perinatal HIV Transmission Study Group. Pediatric Infectious Disease Journal. 1993;12(11):908–913. [PubMed: 8265279]
31.
Sirinavin S, Atamasirikul K. Semiquantitative human immunodeficiency virus antibody tests in diagnosis of vertical infection. Pediatric Infectious Disease Journal. 2000;19(12):1153–1157. [PubMed: 11144375]
32.
World Health Organization; Joint United Nations Programme on HIV/AIDS (UNAIDS). HIV assays: operational characteristics. Geneva: World Health Organization; 2009. [18 December 2009]. http://www​.who.int/diagnostics​_laboratory​/evaluations/hiv/en/index.html.
33.
Ittiravivongs A, et al. Evaluation of a confirmatory HIV testing strategy in Thailand not using western blot. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1996;13(3):296–297. [PubMed: 8898678]
34.
Sato PA, et al. Strategies for laboratory HIV testing: an examination of alternative approaches not requiring Western blot. Bulletin of the World Health Organization. 1994;72(1):129–134. [PMC free article: PMC2486505] [PubMed: 8131248]
35.
Delivering HIV test results and messages for re-testing and counselling in adults. Geneva: World Health Organization; in press. [PubMed: 26269878]
36.
Reynolds SJ, et al. Evaluation of a rapid test for the detection of antibodies to human immunodeficiency virus type 1 and 2 in the setting of multiple transmitted viral subtypes. International Journal of STD and AIDS. 2002;13(3):171–173. [PubMed: 11860693]
37.
Andiman WA, et al. Rate of transmission of human immunodeficiency virus type 1 infection from mother to child and short-term outcome of neonatal infection. Results of a prospective cohort study. American Journal of Diseases of Children. 1990;144(7):758–766. [PubMed: 2113349]
38.
European Collaborative Study. Children born to women with HIV-1 infection: natural history and risk of transmission. Lancet. 1991;337(8736):253–260. [PubMed: 1671109]
39.
Alvarez-Munoz MT, et al. High correlation of human immunodeficiency virus type-1 viral load measured in dried-blood spot samples and in plasma under different storage conditions. Archives of Medical Research. 2005;36(4):382–386. [PubMed: 15950079]
40.
World Health Organization; Joint United Nations Programme on HIV/AIDS (UNAIDS). Guidelines for using HIV testing technologies in surveillance: selection, evaluation, and implementation. Geneva: World Health Organization; 2001. http://whqlibdoc​.who​.int/hq/2001/WHO_CDS_CSR_EDC_2001.16.pdf.
41.
Fischer A, et al. Simple DNA extraction method for dried blood spots and comparison of two PCR assays for diagnosis of vertical human immunodeficiency virus type 1 transmission in Rwanda. Journal of Clinical Microbiology. 2004;42(1):16–20. [PMC free article: PMC321659] [PubMed: 14715726]
42.
Nesheim S, et al. Quantitative RNA testing for diagnosis of HIV-infected infants. Journal of Acquired Immune Deficiency Syndromes. 2003;32(2):192–195. [PubMed: 12571529]
43.
Pineau F, et al. Reliable diagnosis of neonatal HIV-1 infection by real time PCR in Congo; 11th Conference on retroviruses and opportunistic infections; San Francisco, USA. 2004; Poster. http://www​.retroconference​.org/2004/cd/Abstract/900.htm.
44.
Rouet F, et al. Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children. Pediatrics. 2003;112(4):e289. [PubMed: 14523214]
45.
Beck IA, et al. Simple, sensitive, and specific detection of human immunodeficiency virus type 1 subtype B DNA in dried blood samples for diagnosis in infants in the field. Journal of Clinical Microbiology. 2001;39(1):29–33. [PMC free article: PMC87674] [PubMed: 11136743]
46.
Bremer JW, et al. Diagnosis of infection with human immunodeficiency virus type 1 by a DNA polymerase chain reaction assay among infants enrolled in the Women and Infants' Transmission Study. Journal of Pediatrics. 1996;129(2):198–207. [PubMed: 8765616]
47.
Garrido C, et al. Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV load tests. Journal of Clinical Microbiology. 2009;47(4):1031–1036. [PMC free article: PMC2668340] [PubMed: 19193847]
48.
Mwaba P, et al. Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infected African patients. Lancet. 2003;362(9401):2067–2068. [PubMed: 14697808]
49.
Shearer WT, et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. New England Journal of Medicine. 1997;336(19):1337–1342. [PubMed: 9134873]
50.
Braun J, et al. A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes. AIDS. 2003;17(3):331–336. [PubMed: 12556686]
51.
Crowe S, et al. Monitoring of human immunodeficiency virus infection in resource-constrained countries. Clinical Infectious Diseases. 2003;37(Suppl 1):S25–35. [PubMed: 12822129]
52.
Panakitsuwan S, et al. Early diagnosis of vertical HIV infection in infants by rapid detection of immune complex-dissociated HIV p24 antigen. Aids Patient Care and STDS. 1997;11(6):429–433. [PubMed: 11361864]
53.
Rouet F, et al. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting. Journal of Clinical Microbiology. 2005;43(6):2709–2717. [PMC free article: PMC1151915] [PubMed: 15956387]
54.
Sutthent R, et al. p24 Antigen detection assay modified with a booster step for diagnosis and monitoring of human immunodeficiency virus type 1 infection. Journal of Clinical Microbiology. 2003;41(3):1016–1022. [PMC free article: PMC150255] [PubMed: 12624024]
55.
De Baets AJ, et al. Pediatric human immunodeficiency virus screening in an African district hospital. Clinical and Diagnostic Laboratory Immunology. 2005;12(1):86–92. [PMC free article: PMC540202] [PubMed: 15642990]
56.
Patton JC, et al. Ultrasensitive human immunodeficiency virus type 1 p24 antigen assay modified for use on dried whole-blood spots as a reliable, affordable test for infant diagnosis. Clinical and Vaccine Immunology. 2006;13(1):152–155. [PMC free article: PMC1356617] [PubMed: 16426014]
57.
Schüpbach J. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA. AIDS Reviews. 2002;4(2):83–92. [PubMed: 12152521]
58.
Sherman GG, et al. Affordable diagnosis of human immunodeficiency virus infection in infants by p24 antigen detection. Pediatric Infectious Disease Journal. 2004;23(2):173–176. [PubMed: 14872188]
59.
Zijenah LS, et al. Signal-boosted qualitative ultrasensitive p24 antigen assay for diagnosis of subtype C HIV-1 infection in infants under the age of 2 years. Journal of Acquired Immune Deficiency Syndromes. 2005;39(4):391–394. [PubMed: 16010158]
60.
Dunn DT, et al. The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS. 1995;9(9):F7–11. [PubMed: 8527070]
61.
Lambert JS, et al. Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes. 2003;34(5):512–519. [PubMed: 14657763]
62.
Desire N, et al. Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay. Journal of Clinical Microbiology. 2001;39(4):1303–1310. [PMC free article: PMC87929] [PubMed: 11283046]
63.
Sherman GG, et al. Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings. Journal of Acquired Immune Deficiency Syndromes. 2005;38(5):615–617. [PubMed: 15793374]
64.
Khamduang W, et al. Early detection of HIV infection in children born to HIV positive mothers by real time PCR; XV International AIDS Conference; Bangkok, Thailand. 2004; http://www​.iasociety​.org/ejias/show.asp?abstract_id=2168753.
65.
Ginocchio CC, et al. Effects of specimen collection, processing, and storage conditions on stability of human immunodeficiency virus type 1 RNA levels in plasma. Journal of Clinical Microbiology. 1997;35(11):2886–2893. [PMC free article: PMC230081] [PubMed: 9350753]
66.
Galli R, et al. Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1,000 clinical specimens. Journal of Clinical Virology. 2005;34(4):245–252. [PubMed: 16286047]
67.
Michael NL, et al. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes. Journal of Clinical Microbiology. 1999;37(8):2557–2563. [PMC free article: PMC85282] [PubMed: 10405401]
68.
Reisler RB, et al. Early detection of reverse transcriptase activity in plasma of neonates infected with HIV-1: a comparative analysis with RNA-based and DNA-based testing using polymerase chain reaction. Journal of Acquired Immune Deficiency Syndromes. 2001;26(1):93–102. [PubMed: 11176273]
69.
Young NL, et al. Early diagnosis of HIV-1-infected infants in Thailand using RNA and DNA PCR assays sensitive to non-B subtypes. Journal of Acquired Immune Deficiency Syndromes. 2000;24(5):401–407. [PubMed: 11035610]
70.
Triques K, et al. Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1. Journal of Clinical Microbiology. 1999;37(1):110–116. [PMC free article: PMC84180] [PubMed: 9854073]
71.
Simonds RJ, et al. Sensitivity and specificity of a qualitative RNA detection assay to diagnose HIV infection in young infants. Perinatal AIDS Collaborative Transmission Study. AIDS. 1998;12(12):1545–1549. [PubMed: 9727577]
72.
Cassol S, et al. Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper. Journal of Clinical Microbiology. 1997;35(11):2795–2801. [PMC free article: PMC230064] [PubMed: 9350736]
73.
Ribas SG, et al. Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals. Journal of Virological Methods. 2003;113(1):29–34. [PubMed: 14500124]
74.
Luo W, et al. Detection of human immunodeficiency virus type 1 DNA in dried blood spots by a duplex real-time PCR assay. Journal of Clinical Microbiology. 2005;43(4):1851–1857. [PMC free article: PMC1081318] [PubMed: 15815008]
75.
Knuchel MC, et al. Adaptation of the ultrasensitive HIV-1 p24 antigen assay to dried blood spot testing. Journal of Acquired Immune Deficiency Syndromes. 2007;44(3):247–253. [PubMed: 17146373]
76.
Cassol S, et al. Stability of dried blood spot specimens for detection of human immunodeficiency virus DNA by polymerase chain reaction. Journal of Clinical Microbiology. 1992;30(12):3039–3042. [PMC free article: PMC270585] [PubMed: 1452682]
77.
Evengard B, et al. Effect of heat on extracted HIV viral infectivity and antibody activity using the filter paper technique of blood sampling. AIDS. 1989;3(9):591–595. [PubMed: 2506904]
78.
Evengard B, et al. Filter paper sampling of blood infected with HIV: effect of heat on antibody activity and viral infectivity. British Medical Journal. 1988;297(6657):1178. [PMC free article: PMC1834982] [PubMed: 3144339]
79.
Lindhardt BO, et al. Detection of antibodies to human immunodeficiency virus (HIV) in eluates from whole blood impregnated filter paper discs. Journal of Virological Methods. 1987;18(1):73–77. [PubMed: 3480292]
80.
Nyambi PN, et al. Detection of human immunodeficiency virus type 1 (HIV-1) in heel prick blood on filter paper from children born to HIV-1-seropositive mothers. Journal of Clinical Microbiology. 1994;32(11):2858–2860. [PMC free article: PMC264176] [PubMed: 7852588]
81.
Sanchez RG, et al. Diagnostico serologico del VIH-1 en muestras de sangre seca en papel de filtro por el sistema DAVIH Dot VIH-1. [The serological diagnosis of HIV-1 in samples of dried blood on filter paper by the HIV-1 DAVIH Dot system]. Revista Cubana de Medicina Tropical. 1998;50(3):221–222. [PubMed: 10349449]
82.
Comeau AM, et al. Early detection of human immunodeficiency virus on dried blood spot specimens: sensitivity across serial specimens. Women and Infants Transmission Study Group. Journal of Pediatrics. 1996;129(1):111–118. [PubMed: 8757570]
83.
Lakshmi V, et al. Evaluation of the Murex HIV Ag/Ab Combination assay when used with dried blood spots. Clinical Microbiology and Infection. 2007 [PubMed: 17725648]
84.
Ou CY, et al. Identification of HIV-1 infected infants and young children using real-time RT PCR and dried blood spots from Uganda and Cameroon. Journal of Virological Methods. 2007;144(1–2):109–114. [PubMed: 17553573]
85.
Jourbert JJ, et al. A cost-effective particle agglutination assay to detect viral antibodies in dried blood spots - a simple solution to HIV and HCV screening. Central African Journal of Medicine. 2003;49(11–12):127–130. [PubMed: 15301465]
86.
Cassol S, et al. Detection of HIV type 1 env subtypes A, B, C, and E in Asia using dried blood spots: a new surveillance tool for molecular epidemiology. AIDS Research and Human Retroviruses. 1996;12(15):1435–1441. [PubMed: 8893051]
87.
Guide to implementation of services for early diagnosis of infants in resource-limited settings, Book 2: Training curriculum for clinical staff. US Centers for Disease Control, Global AIDS Program, PMTCT Team and International Laboratory Branch; 2009. http://www​.womenchildrenhiv​.org/wchiv?page=ch-09-02-eid.
88.
Bertagnolio S, et al. HIV-1 drug resistance surveillance using dried whole blood spots. Antiviral therapy. 2007;12(1):107–113. [PubMed: 17503754]
89.
Brambilla D, et al. Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability. Journal of Clinical Microbiology. 2003;41(5):1888–1893. [PMC free article: PMC154666] [PubMed: 12734222]
90.
Fiscus SA, et al. Quantitation of human immunodeficiency virus type 1 RNA in plasma by using blood dried on filter paper. Journal of Clinical Microbiology. 1998;36(1):258–260. [PMC free article: PMC124847] [PubMed: 9431960]
91.
Robertson DL, et al. HIV-1 nomenclature proposal: a reference guide to HIV-1 classification. In: Kuiken CL, et al., editors. Human retroviruses and AIDS 1999: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos, NM: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory; 1999. pp. 492–505.
92.
Poulsen AG, et al. HIV-2 infection in Bissau, West Africa, 1987–1989: incidence, prevalences, and routes of transmission. Journal of Acquired Immune Deficiency Syndromes. 1993;6(8):941–948. [PubMed: 8315578]
93.
Poulsen AG, et al. Lack of evidence of vertical transmission of human immunodeficiency virus type 2 in a sample of the general population in Bissau. Journal of Acquired Immune Deficiency Syndromes. 1992;5(1):25–30. [PubMed: 1738085]
94.
Koblavi-Deme S, et al. Sensitivity and specificity of human immunodeficiency virus rapid serologic assays and testing algorithms in an antenatal clinic in Abidjan, Ivory Coast. Journal of Clinical Microbiology. 2001;39(5):1808–1812. [PMC free article: PMC88030] [PubMed: 11325995]
95.
Makuwa M, et al. Reliability of rapid diagnostic tests for HIV variant infection. Journal of Virological Methods. 2002;103(2):183–190. [PubMed: 12008012]
96.
Phillips S, et al. Diagnosis of human immunodeficiency virus type 1 infection with different subtypes using rapid tests. Clinical and Diagnostic Laboratory Immunology. 2000;7(4):698–699. [PMC free article: PMC95937] [PubMed: 10882675]
97.
Rouet F, et al. Early diagnosis of paediatric HIV-1 infection among African breast-fed children using a quantitative plasma HIV RNA assay. AIDS. 2001;15(14):1849–1856. [PubMed: 11579248]
98.
Souza IE, et al. RNA viral load test for early diagnosis of vertical transmission of HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes. 2000;23(4):358–360. [PubMed: 10836762]
99.
Kline MW, et al. A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection. Pediatric Infectious Disease Journal. 1994;13(2):90–94. [PubMed: 8190557]
100.
Kovacs A, et al. Comparison of a rapid nonisotopic polymerase chain reaction assay with four commonly used methods for the early diagnosis of human immunodeficiency virus type 1 infection in neonates and children. Pediatric Infectious Disease Journal. 1995;14(11):948–954. [PubMed: 8584360]
101.
Prasitwattanaseree S, et al. Influence of mother and infant zidovudine treatment duration on the age at which HIV infection can be detected by polymerase chain reaction in infants. Antiviral therapy. 2004;9(2):179–185. [PubMed: 15134179]
Copyright © 2010, World Health Organization.

All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: tni.ohw@sredrokoob). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: tni.ohw@snoissimrep).

Bookshelf ID: NBK138561

Views

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...